Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.44 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | GLB1 | P16278 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28341435 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| SCHEMBL6506788 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| SCHEMBL6506197 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| SCHEMBL60452 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| SCHEMBL18180403 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| SCHEMBL20733674 | 1.00 | HRH3 (0.65) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| Butane SCHEMBL2507294 | 0.97 | HRH3 (0.62) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| Hydrochloric Acid SCHEMBL15141354 | 0.97 | HRH3 (0.62) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| Water SCHEMBL28467820 | 0.97 | HRH3 (0.62) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 | |
| Ammonia Solution, Strong SCHEMBL8765175 | 0.97 | HRH3 (0.62) | HRH3CYP1A2MAPK1SMN1; SMN2GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119421921-A | Rubber composition for tire and tire | 株式会社普利司通 | 2025-02-11 | — | — | CN | disclosed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-12098226-B2 | Polymer, method for producing polymer, and method for producing membrane | AGC Inc. (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240224789-A1 | IONIC COMPOUND AND APPLICATION THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRIC APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2024-07-04 | — | — | US | disclosed |
| CN-118043309-A | Ionic compound and application thereof, perovskite precursor solution, perovskite material, solar cell and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2024063100-A1 | METHOD FOR PRODUCING POLYVALENT CARBODIIMIDE B | 旭化成株式会社 | 2024-03-28 | — | — | WO | disclosed |
| EP-4321505-A1 | IONIC COMPOUND AND USE THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRICAL DEVICE | Contemporary Amperex Technology Co., Ltd. (CN) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023240629-A1 | IONIC COMPOUND AND USE THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRICAL DEVICE | 宁德时代新能源科技股份有限公司 | 2023-12-21 | — | — | WO | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1719768-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | Asahi Kasei Pharma Corporation (JP) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005082892-A2 | TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-09-09 | — | — | WO | disclosed |
| EP-1535913-A1 | NOVEL QUATERNARY AMMONIUM COMPOUNDS | Asahi Kasei Pharma Corporation (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-0628585-B1 | Advancement catalyst containing epoxy resin compositions | CIBA GEIGY (CH) | 1997-06-04 | — | — | EP | disclosed |
| US-5521261-A | PERHYDROAZEPINIUM OR OCTAHYDROAZOCINIUM SALT FOR CHAIN EXTENSION | CIBA-GEIGY CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0628585-A2 | Advancement catalyst containing epoxy resin compositions | CIBA-GEIGY AG (CH) | 1994-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | HRH3 2167/4885CYP1A2 1339/4885MAPK1 2622/4885 |
| US-20240224789-A1 | IONIC COMPOUND AND APPLICATION THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRIC APPARATUS | HCN2, HCN1, PIEZO1 | HRH3 3067/4885CYP1A2 3441/4885MAPK1 205/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | HRH3 404/4885CYP1A2 851/4885MAPK1 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.